auto_awesome
Want to know who else bid on this?
ProposalForge correlates this contract with the original RFP, the losing bidders, and the next recompete window.
Recipient
Resilience Biotechnologies Inc.Amount
$199.2M
Program
SIF Stream 2 - GrowthProvince
ONType
Contribution
Agreement Number
033-2021-2022-Q1-816022
Purpose
This project will help develop Canada's medical countermeasures to COVID-19 and future pandemics by expanding RBI's manufacturing capabilities to create additional vaccine, therapy and fill/finish capacity at its Mississauga, Ontario site.
Resilience Biotechnologies Inc. × Innovation, Science and Economic Development Canada
3 grants totalling $492.2M
SIF Stream 2 - Growth
18 grants totalling $1.4B
Related Grants
| Recipient | Amount | Program |
|---|---|---|
| Air Products Canada Ltd. | $300.0M | SIF Stream 2 - Growth |
| AbCellera Biologics Inc. | $175.6M | SIF Stream 2 - Growth |
| Linamar Corporation | $169.4M | SIF Stream 2 - Growth |
| ArcelorMittal Mining Canada G.P.|ArcelorMittal Exploitation Minière Canada s.e.n.c. | $125.0M | SIF Stream 2 - Growth |
| Resilience Biotechnologies Inc. | $93.8M | SIF Stream 2 - Growth |